Cargando…
SetD7 (Set7/9) is a novel target of PPARγ that promotes the adaptive pancreatic β-cell glycemic response
Loss of functional pancreatic β-cell mass leads to type 2 diabetes (T2D), attributable to modified β-cell-dependent adaptive gene expression patterns. SetD7 is a histone methyltransferase enriched in pancreatic islets that mono- and dimethylates histone-3-lysine-4 (H3K4), promoting euchromatin modif...
Autores principales: | Jetton, Thomas L., Flores-Bringas, Patricio, Leahy, John L., Gupta, Dhananjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526774/ https://www.ncbi.nlm.nih.gov/pubmed/34592314 http://dx.doi.org/10.1016/j.jbc.2021.101250 |
Ejemplares similares
-
Physiologic and Pharmacologic Modulation of Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Expression in β-Cells by Peroxisome Proliferator–Activated Receptor (PPAR)-γ Signaling: Possible Mechanism for the GIP Resistance in Type 2 Diabetes
por: Gupta, Dhananjay, et al.
Publicado: (2010) -
Lysine Methyltransferase SETD7 (SET7/9) Regulates ROS Signaling through mitochondria and NFE2L2/ARE pathway
por: He, Shuying, et al.
Publicado: (2015) -
Histone lysine methyltransferase Pr‐set7/SETD8 promotes neural stem cell reactivation
por: Huang, Jiawen, et al.
Publicado: (2021) -
Insights into the stereoselectivity of human SETD7 methyltransferase
por: Tang, Bowen, et al.
Publicado: (2019) -
SETD7 Regulates the Differentiation of Human Embryonic Stem Cells
por: Castaño, Julio, et al.
Publicado: (2016)